Hiroshi Tada

Associate Professor

Tohoku University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hiroshi Tada is an Associate Professor at Tohoku University in Japan. His research focuses on breast cancer, including the clinicopathogenomic analysis of PI3K/AKT/PTEN alterations and the evaluation of cell-free DNA in treatment responses. He has contributed to significant studies on cancer genomic profiling and the identification of prognostic biomarkers in cancer therapy.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

JAPAN

View details

Minoru Miyashita

Tohoku University

JAPAN

View details

Katsutoshi Oda

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hiroshi Tada

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Clinicopathogenomic analysis of PI3K/AKT/PTEN-altered luminal metastatic breast cancer in Japan

Nationwide survey of the secondary findings in cancer genomic profiling: survey including liquid biopsy

Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer Chemoresistance

Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing

Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing

Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer

Surgical and irradiated case of early breast cancer in a patient with Ehlers–Danlos syndrome

Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer

Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity

Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity

Clinical Significance of ABCG2/BCRP Quantified by Fluorescent Nanoparticles in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study

Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer

Collaborators (10)

Shozo Furumoto

Hiroyuki Shibata

Takashi Suzuki

Takahiro Yamada

Ichiro Yabe

Hidetaka Niizuma

Takashi Takeshita

Tomoyoshi Soga

Minoru Miyashita

Katsutoshi Oda

Make your next move.